Our findings provide new insights into understanding the molecular mechanisms behind FGD1/CDC42-dependent transport events and uncover new targets whose potential might be explored for correction of membrane trafficking in FGDY. This evidence concerns the gene FGD1 and Aarskog-Scott syndrome, X-linked.